Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride

Urology

Volumn 58, Issue 6, 2001, Pages 972-976

  Sandfeldt, Lars ^a   Bailey, David M ^b   Hahn, Robert G ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b WYCOMBE HOSPITAL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PEROXIDASE; PLACEBO;

ABSORPTION; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; LIQUID; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OPERATION DURATION; PRIORITY JOURNAL; PROSTATE; RANDOMIZED CONTROLLED TRIAL; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; WEIGHT;

ABSORPTION; AGED; BLOOD LOSS, SURGICAL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FINASTERIDE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PILOT PROJECTS; PROSTATE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0035667075     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01408-X     Document Type: Article

References (27)

1. Factors influencing morbidity in patients undergoing transurethral resection of the prostate
2. Is transurethral resection of the prostate still justified?
3. Symptoms of the transurethral resection syndrome using glycine as the irrigant
4. Double-blind randomized study of symptoms associated with absorption of glycine 1.5% or mannitol 3% during transurethral resection of the prostate
5. Endocrine therapies for symptomatic benign prostatic hyperplasia
6. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
7. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
8. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: Long-term follow-up
9. The treatment of gross hematuria secondary to prostatic bleeding with finasteride
10. Treatment of prostatic bleeding: Suppression of angiogenesis by androgen deprivation
11. Microvessel density in prostatic hyperplasia
12. Effects of finasteride and bicalutamide on prostatic blood flow in the rat
13. Reduction of prostatic blood flow by finasteride
14. Effect of finasteride on microvessel density (MVD) in patients with recurrent hematuria related to prostatic hypertrophy (BPH)
15. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue
16. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats
17. Ten-language translation and harmonization of the International Prostate Symptom Score: Developing a methodology for multinational clinical trials
18. Determination of prostate volume by transrectal ultrasound
19. Blood loss during transurethral resection of the prostate as measured by the HemoCue photometer
20. A simple photometric method for determination of blood loss during transurethral surgery
21. Ethanol monitoring of irrigating fluid absorption
22. Calculation of irrigant absorption by measurement of breath alcohol level during transurethral resection of the prostate
23. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
24. Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate
25. Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol
26. Expired breath ethanol measurement to calculate irrigating fluid absorption during transurethral resection of the prostate: Experience in a district general hospital
27. Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate